First results of the Phase III GIMEMA ALL2820 trial comparing ponatinib plus blinatumomab to imatinib and chemotherapy for newly diagnosed adult ph+ acute lymphoblastic leukemia patientsSabina Chiaretti, Paola Fazi, Mariangela Di Trani et al.|Blood|2025Cited by 12
Severe COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia or Indolent B-Cell Non-Hodgkin Lymphoma Who Received Pre-Exposure Prophylaxis with Tixagevimab and Cilgavimab in Italy: Preliminary Results of the Observational Study By the Gimema Working Party on Chronic Lymphoproliferative Disorders and By the Fondazione Italiana LinfomiGian Matteo Rigolin, Antonio Cuneo, Riccardo Dondolin et al.|Blood|2024Cited by 0